Elsevier Nanotechnology in Cancer Management: Precise Diagnostics toward Personalized Health Care

Nanotechnology in Cancer Management: Precise Diagnostics toward Personalized Health Care provides a well-focused and comprehensive overview of technologies involved in early stage cancer diagnostics via the detection of various cancer biomarkers, both in-vitro and in-vivo. The book briefly describes the advancement in cancer biomarker research relating to cancer diagnostics, covering fundamental aspects of various techniques, especially transduction methodologies, such as electrochemical, optical, magnetic, etc. In addition, it describes approaches on how to make options cost-effective, scalable for clinical application, and user-friendly. Advancements in technology related to device miniaturization, performance improvement and point-of-care applications round out discussions. Final sections cover future challenges, the prospects of various techniques, and how the introduction of nanotechnology in cancer management in a personalized manner is useful. Review Comprehensive overview of technologies involved in early stage cancer diagnostics via the detection of various cancer biomarkers, in-vivo and in-vitro From the Back Cover Nanotechnology in Cancer Management: Precise Diagnostics toward Personalized Health Care provides a well-focused and comprehensive overview of technologies involved in early stage cancer diagnostics via the detection of various cancer biomarkers, both in-vitro and in-vivo. The book briefly describes the advancement in cancer biomarker research relating to cancer diagnostics, covering fundamental aspects of various techniques, especially transduction methodologies, such as electrochemical, optical, magnetic, etc. In addition, it describes approaches on how to make options cost-effective, scalable for clinical application, and user-friendly. Advancements in technology related to device miniaturization, performance improvement and point-of-care applications round out discussions. Final sections cover future challenges, the prospects of various techniques, and how the introduction of nanotechnology in cancer management in a personalized manner is useful. About the Author Dr. Kamil Reza Khondakar obtained his doctoral degree from the Centre of Personalised Nanomedicine in the Trau group, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Australia. He is currently involved in the multiple surface marker profiling of cancer cells and monitor the drug sensitivity effect on the cell surface markers in a Raman (SERS) based microfluidic chip. The aim of his studies is focused on the development of next-generation diagnostics chips for multiple biomarker detection on a single chip to understand the tumor heterogeneity and provide an early detection strategy for cancer management. Prior to this, he worked as a researcher in DST Center at Biomedical Instrumentation Section, National Physical Laboratory, India. His research activities included development of thin film-based microelectrodes using various nanostructures, nanocomposites for biomedical applications. He received awards and honors due to his contributions to the field of biomedical technology. He was awarded International Postgraduate Research Scholarship (IPRS) from Government of Australia, and University of Queensland Centennial Scholarship (UQCent) from The University of Queensland, Australia. He was invited to give a talk at ‘Biosensor 2018’ conference at Miami, USA. Dr. Kaushik I M.Sc., Ph.D., Fellow-Indian Chemical Society I, an associate professor of chemistry at Florida Polytechnic University, is exploring nano-technology, material science, thin films, miniaturized sensors, electrochemistry, electrochemical biosensors, nanomedicine, drug delivery to CNS, and biomedical engineering for health wellness. Dr. Kaushik received his Ph.D. (chemistry and nano-enabled biosensors) in collaboration with National Physical Laboratory and Jamia Milia Islamia, New